VERITAS IN SILICO Trademark

Trademark Overview


On Friday, June 5, 2020, a trademark application was filed for VERITAS IN SILICO with the United States Patent and Trademark Office. The USPTO has given the VERITAS IN SILICO trademark a serial number of 79295799. The federal status of this trademark filing is REGISTERED as of Tuesday, September 20, 2022. This trademark is owned by Veritas In Silico Inc.. The VERITAS IN SILICO trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Educational and instruction services, namely, organizing events for educational and teaching purposes relating to arts, crafts, sports and general knowledge; teaching in the field of drug discovery and development; educating at universities and graduate schools; arranging, conducting and organization of seminars; arranging, conducting and organization of symposiums, lecture meetings, workshops and study groups; arranging, conducting and organization of educational seminars, symposiums, lecture meetings, workshops and study groups in the field of drug discovery and development; providing online non-downloadable electronic publications in the nature of magazines, newsletters, journals and books in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; reference libraries of literature and documentary records; book rental; providing online music, sound recordings, videos featuring information and instruction on nucleic acids, phar...

Custom manufacturing of pharmaceuticals for others; custom synthesis in the nature of custom manufacturing of nucleic acids for others for use in medicines and pharmaceutical preparations; custom extraction, purification, and synthesis, namely, custom manufacturing of pharmaceuticals for others by utilizing genome editing or gene editing technology; custom synthesis in the nature of custom manufacturing of chemical compounds for others for use in medicines and pharmaceutical preparations; custom synthesis in the nature of custom manufacturing of chemical compounds for others; providing material treatment information; printing

Pharmaceutical preparations targeting messenger RNA or other types of RNA for the treatment of autoimmune, autoinflammatory diseases, bacterial infections, behavioral and mental disorders, blood diseases, chromosome disorders, congenital and genetic diseases, connective tissue diseases, digestive diseases, ear diseases, nose diseases, throat diseases, endocrine diseases, environmental diseases, eye diseases, female reproductive diseases, fungal infections, heart diseases, hereditary cancer syndromes, immune system diseases, kidney and urinary diseases, lung diseases, male reproductive diseases, metabolic disorders, mouth diseases, musculoskeletal diseases, myelodysplastic syndromes, nervous system diseases, newborn screening, nutritional diseases, parasitic diseases, rare cancers, rare diseases, skin diseases and viral infections; reagent paper for medical purposes; pharmaceutical preparations targeting messenger RNA or other types of RNA, other than for agricultural purposes for the t...

Chemicals, namely chemicals for use in medical industry and medical science; small molecule compounds as chemicals for use in medical science and medical industry; nucleic acids for laboratory use excluding the use in industrial chemistry, other than for medical or veterinary purposes; nucleic acid chemical reagents excluding the use in research or development in industrial chemistry, other than for medical or veterinary purposes; reagents and assays for use in scientific, medical or drug discovery research; reagents for chemical analyses, excluding the use in research or development in industrial chemistry, other than for medical or veterinary purposes; reagents for nucleic acid isolation and purification for medical and drug discovery research purposes; reagents for nucleic acid synthesis and analysis for medical and drug discovery research purposes; diagnostic preparations and assay samples for medical and drug discovery research, clinical research, and laboratory use, other than fo...

Custom design of chemical reagents and biological assays for use in medicines and engineering design services, not for advertising; development of pharmaceutical preparations and medicines; computer software design, computer programming, and maintenance of computer software for use in RNA targeted drug discovery and development; designing, programming and maintenance of computer software having artificial intelligence functionality for use in RNA targeted drug discovery and development; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence for use in RNA targeted drug discovery and development; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals for use in medicines for use in RNA targeted drug discovery and development; ...
veritas in silico

General Information


Serial Number79295799
Word MarkVERITAS IN SILICO
Filing DateFriday, June 5, 2020
Status700 - REGISTERED
Status DateTuesday, September 20, 2022
Registration Number6848721
Registration DateTuesday, September 20, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements


Goods and ServicesEducational and instruction services, namely, organizing events for educational and teaching purposes relating to arts, crafts, sports and general knowledge; teaching in the field of drug discovery and development; educating at universities and graduate schools; arranging, conducting and organization of seminars; arranging, conducting and organization of symposiums, lecture meetings, workshops and study groups; arranging, conducting and organization of educational seminars, symposiums, lecture meetings, workshops and study groups in the field of drug discovery and development; providing online non-downloadable electronic publications in the nature of magazines, newsletters, journals and books in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; reference libraries of literature and documentary records; book rental; providing online music, sound recordings, videos featuring information and instruction on nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering, images and character text information, non-downloadable; educational services in the nature of providing exhibits of academic materials in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; art exhibitions; publication of books; movie theatre presentations, namely, movie showing and movie film production and distribution; production of videotape film in the field of education, culture, entertainment or sports, not for movies or television programs and not for advertising or publicity
Goods and ServicesCustom manufacturing of pharmaceuticals for others; custom synthesis in the nature of custom manufacturing of nucleic acids for others for use in medicines and pharmaceutical preparations; custom extraction, purification, and synthesis, namely, custom manufacturing of pharmaceuticals for others by utilizing genome editing or gene editing technology; custom synthesis in the nature of custom manufacturing of chemical compounds for others for use in medicines and pharmaceutical preparations; custom synthesis in the nature of custom manufacturing of chemical compounds for others; providing material treatment information; printing
Goods and ServicesPharmaceutical preparations targeting messenger RNA or other types of RNA for the treatment of autoimmune, autoinflammatory diseases, bacterial infections, behavioral and mental disorders, blood diseases, chromosome disorders, congenital and genetic diseases, connective tissue diseases, digestive diseases, ear diseases, nose diseases, throat diseases, endocrine diseases, environmental diseases, eye diseases, female reproductive diseases, fungal infections, heart diseases, hereditary cancer syndromes, immune system diseases, kidney and urinary diseases, lung diseases, male reproductive diseases, metabolic disorders, mouth diseases, musculoskeletal diseases, myelodysplastic syndromes, nervous system diseases, newborn screening, nutritional diseases, parasitic diseases, rare cancers, rare diseases, skin diseases and viral infections; reagent paper for medical purposes; pharmaceutical preparations targeting messenger RNA or other types of RNA, other than for agricultural purposes for the treatment of autoimmune, autoinflammatory diseases, bacterial infections, behavioral and mental disorders, blood diseases, chromosome disorders, congenital and genetic diseases, connective tissue diseases, digestive diseases, ear diseases, nose diseases, throat diseases, endocrine diseases, environmental diseases, eye diseases, female reproductive diseases, fungal infections, heart diseases, hereditary cancer syndromes, immune system diseases, kidney and urinary diseases, lung diseases, male reproductive diseases, metabolic disorders, mouth diseases, musculoskeletal diseases, myelodysplastic syndromes, nervous system diseases, newborn screening, nutritional diseases, parasitic diseases, rare cancers, rare diseases, skin diseases and viral infections; drugs for medical purposes, targeting messenger RNA or other types of RNA for the treatment of autoimmune, autoinflammatory diseases, bacterial infections, behavioral and mental disorders, blood diseases, chromosome disorders, congenital and genetic diseases, connective tissue diseases, digestive diseases, ear diseases, nose diseases, throat diseases, endocrine diseases, environmental diseases, eye diseases, female reproductive diseases, fungal infections, heart diseases, hereditary cancer syndromes, immune system diseases, kidney and urinary diseases, lung diseases, male reproductive diseases, metabolic disorders, mouth diseases, musculoskeletal diseases, myelodysplastic syndromes, nervous system diseases, newborn screening, nutritional diseases, parasitic diseases, rare cancers, rare diseases, skin diseases and viral infections; biological preparations for medical purposes, targeting messenger RNA or other types of RNA for the treatment of autoimmune, autoinflammatory diseases, bacterial infections, behavioral and mental disorders, blood diseases, chromosome disorders, congenital and genetic diseases, connective tissue diseases, digestive diseases, ear diseases, nose diseases, throat diseases, endocrine diseases, environmental diseases, eye diseases, female reproductive diseases, fungal infections, heart diseases, hereditary cancer syndromes, immune system diseases, kidney and urinary diseases, lung diseases, male reproductive diseases, metabolic disorders, mouth diseases, musculoskeletal diseases, myelodysplastic syndromes, nervous system diseases, newborn screening, nutritional diseases, parasitic diseases, rare cancers, rare diseases, skin diseases and viral infections; nucleic acid sequences for medical and veterinary purposes; cells for medical purposes; blood for medical purposes; diagnostic and therapeutic antibodies for medical purposes; vaccines; enzyme inhibitors, only for medical or veterinary purposes; medical assay preparations for therapeutic or diagnostic purposes; medical diagnostic reagents; reagents for medical purposes; reagents for extracting nucleic acids, only for medical or veterinary diagnostic purposes; pharmaceutical preparations containing nucleic acids, targeting messenger RNA or other types of RNA for the treatment of autoimmune, autoinflammatory diseases, bacterial infections, behavioral and mental disorders, blood diseases, chromosome disorders, congenital and genetic diseases, connective tissue diseases, digestive diseases, ear diseases, nose diseases, throat diseases, endocrine diseases, environmental diseases, eye diseases, female reproductive diseases, fungal infections, heart diseases, hereditary cancer syndromes, immune system diseases, kidney and urinary diseases, lung diseases, male reproductive diseases, metabolic disorders, mouth diseases, musculoskeletal diseases, myelodysplastic syndromes, nervous system diseases, newborn screening, nutritional diseases, parasitic diseases, rare cancers, rare diseases, skin diseases and viral infections; reagents for detection, identification, analysis and quantification of nucleic acids for pharmaceutical and diagnostic medical purposes; enzymes for medical purposes; lacteal flour for babies; dietary supplements for humans; dietetic foods in liquid form adapted for medical purposes; dietetic foods adapted for medical purposes; beverages, namely, dietetic foods in the form of liquid for babies; food for babies; dietary supplements for animals
Goods and ServicesChemicals, namely chemicals for use in medical industry and medical science; small molecule compounds as chemicals for use in medical science and medical industry; nucleic acids for laboratory use excluding the use in industrial chemistry, other than for medical or veterinary purposes; nucleic acid chemical reagents excluding the use in research or development in industrial chemistry, other than for medical or veterinary purposes; reagents and assays for use in scientific, medical or drug discovery research; reagents for chemical analyses, excluding the use in research or development in industrial chemistry, other than for medical or veterinary purposes; reagents for nucleic acid isolation and purification for medical and drug discovery research purposes; reagents for nucleic acid synthesis and analysis for medical and drug discovery research purposes; diagnostic preparations and assay samples for medical and drug discovery research, clinical research, and laboratory use, other than for medical or veterinary purposes; proteins in raw material form and enzymes for scientific and medical research purposes; cells for research or scientific purposes; nucleic acid, namely, DNA deoxyribonucleic acids for laboratory use; nucleic acid, namely, RNA ribonucleic acids for laboratory use; antibodies, namely, antibody reagents for research use, other than for medical or veterinary purposes; artificial sweeteners; raw materials, namely, unprocessed plastics in all forms; none of the foregoing for use in research or development in industrial chemistry
NOT AVAILABLE"IN SILICO"
Goods and ServicesCustom design of chemical reagents and biological assays for use in medicines and engineering design services, not for advertising; development of pharmaceutical preparations and medicines; computer software design, computer programming, and maintenance of computer software for use in RNA targeted drug discovery and development; designing, programming and maintenance of computer software having artificial intelligence functionality for use in RNA targeted drug discovery and development; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence for use in RNA targeted drug discovery and development; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals for use in medicines for use in RNA targeted drug discovery and development; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer programming, and maintenance of computer software for use in genome research or treatments, pharmaceutical preparations for RNA targeted drug discovery and development; technological advice relating to computers, automobiles and other industrial machines requiring highly specialized knowledge, skills and experiences for proper operation, namely, computer technology consultancy and industrial machine part design consulting for use in RNA targeted drug discovery and development; scientific research, testing and analysis in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicines, chemicals and engineering for use in RNA targeted drug discovery and development; quality control assessment services for use in RNA targeted drug discovery and development for others; testing, inspection or research of pharmaceuticals for use in RNA targeted drug discovery and development; providing information and consultancy on testing, inspection or research of pharmaceuticals, chemicals for use in medicines, reagents for use in medicines for use in RNA targeted drug discovery and development; scientific or laboratory testing, inspection or research of nucleic acids, chemicals and pharmaceuticals for drug development and medical research purposes, and providing scientific information and research consultancy relating thereto for use in RNA targeted drug discovery and development; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto for use in RNA targeted drug discovery and development; genomic experiments, analyses, research, assays, tests, inspection, detection or verification, namely, scientific genomic analyses, scientific genomic research, custom design and development of biochemical genomic assays, genome amplification and functional and structural analysis of genomes for use in RNA targeted drug discovery and development; scientific research consultancy, advice and providing scientific research information in the field of genomic experiments, analyses, research, assays, tests, inspection, detection or verification for use in RNA targeted drug discovery and development; scientific and technological services, namely, testing, analysis surveying, research or data analysis in the field of biomedicine, genome biology, pharmacogenomics, diagnostics, clinical trials and bioengineering for use in RNA targeted drug discovery and development; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceuticals for use in RNA targeted drug discovery and development for others; rental of computers; providing computer programs on data networks, namely, providing temporary use of non-downloadable computer software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; providing online non-downloadable computer software for analyzing science and technology data based on artificial intelligence (AI) technology for use in RNA targeted drug discovery and development; providing online non-downloadable computer software for analyzing, testing, screening, designing, developing and researching of nucleic acids, pharmaceuticals and chemicals for use in RNA targeted drug discovery and development; providing online non-downloadable computer software for drug discovery screening; providing online non-downloadable computer software for conducting and accessing genome research and treatments, pharmaceutical preparations for use in RNA targeted drug discovery and development

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVeritas In Silico Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameVeritas In Silico Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameVeritas In Silico Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, October 15, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, October 22, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 19, 2020ASSIGNED TO EXAMINER
Wednesday, October 21, 2020NON-FINAL ACTION WRITTEN
Friday, October 23, 2020APPLICATION FILING RECEIPT MAILED
Thursday, November 12, 2020REFUSAL PROCESSED BY MPU
Thursday, November 12, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, November 29, 2020REFUSAL PROCESSED BY IB
Monday, May 10, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 24, 2021NON-FINAL ACTION WRITTEN
Thursday, June 24, 2021NON-FINAL ACTION E-MAILED
Thursday, June 24, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 8, 2022LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, March 2, 2022LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 16, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 16, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, March 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, April 10, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sunday, April 10, 2022NOTIFICATION PROCESSED BY IB
Thursday, April 28, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 10, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, May 24, 2022ASSIGNED TO PETITION STAFF
Wednesday, May 25, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Sunday, August 14, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, September 20, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 11, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, October 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 20, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, December 22, 2022FINAL DISPOSITION PROCESSED
Thursday, December 22, 2022FINAL DISPOSITION NOTICE SENT TO IB
Sunday, January 15, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, November 25, 2023LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, January 23, 2024LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Tuesday, August 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 20, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED